{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T14:38:53Z","timestamp":1781102333441,"version":"3.54.1"},"reference-count":33,"publisher":"Japanese Society for Pediatric Endocrinology","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Pediatr Endocrinol"],"published-print":{"date-parts":[[2022]]},"DOI":"10.1297\/cpe.2022-0018","type":"journal-article","created":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T18:09:33Z","timestamp":1656526173000},"page":"225-233","source":"Crossref","is-referenced-by-count":1,"title":["Experience with enteral sulfonylurea monotherapy for extremely low birth weight infants with hyperglycemia"],"prefix":"10.1297","volume":"31","author":[{"given":"Ai","family":"Nakagawa","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Machida Municipal Hospital, Tokyo, Japan"},{"name":"Department of Pediatrics, The Jikei University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daishi","family":"Hirano","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The Jikei University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Inage","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The Jikei University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saya","family":"Yamada","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The Jikei University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Kotake","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The Jikei University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohiro","family":"Ikoma","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The Jikei University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Kumazawa","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The Jikei University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shion","family":"Hayashi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The Jikei University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukitoshi","family":"Tanabe","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The Jikei University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahisa","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The Jikei University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Division of Neonatology, Saitama Children\u2019s Medical Center, Saitama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"125","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Hays, SP, Smith, EO, Sunehag, AL. Hyperglycemia is a risk factor for early death and morbidity in extremely low birth-weight infants. Pediatrics 2006;118: 1811\u20138.","DOI":"10.1542\/peds.2006-0628"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Blanco, CL, Baillargeon, JG, Morrison, RL, Gong, AK. Hyperglycemia in extremely low birth weight infants in a predominantly Hispanic population and related morbidities. J Perinatol 2006;26: 737\u201341.","DOI":"10.1038\/sj.jp.7211594"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Soghier, LM, Brion, LP. Multivariate analysis of hyperglycemia in extremely low birth weight infants. J Perinatol 2006;26: 723\u20135.","DOI":"10.1038\/sj.jp.7211614"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Kao, LS, Morris, BH, Lally, KP, Stewart, CD, Huseby, V, Kennedy, KA. Hyperglycemia and morbidity and mortality in extremely low birth weight infants. J Perinatol 2006;26: 730\u20136.","DOI":"10.1038\/sj.jp.7211593"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Decaro, MH, Vain, NE. Hyperglycaemia in preterm neonates: what to know, what to do. Early Hum Dev 2011;87(Suppl 1): S19\u201322.","DOI":"10.1016\/j.earlhumdev.2011.01.005"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. American Academy of Paediatrics Committee on Nutrition. Nutritional needs of low-birth-weight infants. Pediatrics 1985;75: 976\u201386.","DOI":"10.1542\/peds.75.5.976"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Beardsall, K, Vanhaesebrouck, S, Ogilvy-Stuart, AL, Vanhole, C, Palmer, CR, van Weissenbruch, M, et al. Early insulin therapy in very-low-birth-weight infants. N Engl J Med 2008;359: 1873\u201384.","DOI":"10.1056\/NEJMoa0803725"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Alsweiler, JM, Harding, JE, Bloomfield, FH. Tight glycemic control with insulin in hyperglycemic preterm babies: a randomized controlled trial. Pediatrics 2012;129: 639\u201347.","DOI":"10.1542\/peds.2011-2470"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Tottman, AC, Alsweiler, JM, Bloomfield, FH, Gamble, G, Jiang, Y, Leung, M, et al. PIANO Study Group. Long-term outcomes of hyperglycemic preterm infants randomized to tight glycemic control. J Pediatr 2018;193: 68\u201375.e1.","DOI":"10.1016\/j.jpeds.2017.09.081"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Beardsall, K, Thomson, L, Elleri, D, Dunger, DB, Hovorka, R. Feasibility of automated insulin delivery guided by continuous glucose monitoring in preterm infants. Arch Dis Child Fetal Neonatal Ed 2020;105: 279\u201384.","DOI":"10.1136\/archdischild-2019-316871"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Bansal, A, Bloomfield, FH, Connor, KL, Dragunow, M, Thorstensen, EB, Oliver, MH, et al. Glucocorticoid-induced preterm birth and neonatal hyperglycemia alter ovine \u03b2-cell development. Endocrinology 2015;156: 3763\u201376.","DOI":"10.1210\/en.2015-1095"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Sinclair, JC, Bottino, M, Cowett, RM. Interventions for prevention of neonatal hyperglycemia in very low birth weight infants. Cochrane Database Sys Rev  2009: CD 007615. https:\/\/doi:10.1002\/14651858.CD007615.pub2.","DOI":"10.1002\/14651858.CD007615.pub2"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Lemelman, MB, Letourneau, L, Greeley, SAW. Neonatal diabetes mellitus: an update on diagnosis and management. Clin Perinatol 2018;45: 41\u201359.","DOI":"10.1016\/j.clp.2017.10.006"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Pearson, ER, Flechtner, I, Nj\u00f8lstad, PR, Malecki, MT, Flanagan, SE, Larkin, B, et al. Neonatal Diabetes International Collaborative Group. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med 2006;355: 467\u201377.","DOI":"10.1056\/NEJMoa061759"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Carmody, D, Bell, CD, Hwang, JL, Dickens, JT, Sima, DI, Felipe, DL, et al. Sulfonylurea treatment before genetic testing in neonatal diabetes: pros and cons. J Clin Endocrinol Metab 2014;99: E2709\u201314.","DOI":"10.1210\/jc.2014-2494"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Loomba-Albrecht, LA, Glaser, NS, Styne, DM, Bremer, AA. An oral sulfonylurea in the treatment of transient neonatal diabetes mellitus. Clin Ther 2009;31: 816\u201320.","DOI":"10.1016\/j.clinthera.2009.04.003"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Zamir, I, Tornevi, A, Abrahamsson, T, Ahlsson, F, Engstr\u00f6m, E, Hallberg, B, et al. Hyperglycemia in extremely preterm infants-insulin treatment, mortality and nutrient intakes. J Pediatr 2018;200: 104\u2013110.e1.","DOI":"10.1016\/j.jpeds.2018.03.049"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. McKinlay, CJ, Alsweiler, JM, Ansell, JM, Anstice, NS, Chase, JG, Gamble, GD, et al. CHYLD Study Group. Neonatal glycemia and neurodevelopmental outcomes at 2 years. N Engl J Med 2015;373: 1507\u201318.","DOI":"10.1056\/NEJMoa1504909"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Abraham, MB, Jones, TW, Naranjo, D, Karges, B, Oduwole, A, Tauschmann, M, et al. ISPAD Clinical Practice Consensus Guidelines 2018: Assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatr Diabetes 2018;19(Suppl 27): 178\u201392.","DOI":"10.1111\/pedi.12698"},{"key":"20","unstructured":"20. US Department of Health and Human Services National Institutes of Health NCI. Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0. Available at https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/docs\/CTCAE_v5_Quick_Reference_5x7.pdf. Accessed October 1, 2021."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Lv, Y, Zhu, LL, Shu, GH. Relationship between blood glucose fluctuation and brain damage in the hypoglycemia neonates. Am J Perinatol 2018;35: 946\u201350.","DOI":"10.1055\/s-0038-1626706"},{"key":"22","unstructured":"22. Ota, K, Doumoto, T, Togawa, M, Tamura, A, Utsunomiya, Y, Tsunei, M, et al. A successful case of sulfonylurea for neonatal diabetes mellitus in a very-low-birth-weight newborn infant. J Tottori Med Assoc 2019;47: 79\u201383."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Beltrand, J, Baptiste, A, Busiah, K, Bouazza, N, Godot, C, Boucheron, A, et al. GLID-KIR study group. Glibenclamide oral suspension: Suitable and effective in patients with neonatal diabetes. Pediatr Diabetes 2019;20: 246\u201354.","DOI":"10.1111\/pedi.12823"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Bouazza, N, Djerada, Z, Gozalo, C, Busiah, K, Beltrand, J, Berdugo, M, et al. Evaluation of the pharmacokinetics of glibenclamide tablet given, off label, orally to children suffering from neonatal syndromic hyperglycemia. Eur J Clin Pharmacol 2016;72: 1373\u20139.","DOI":"10.1007\/s00228-016-2119-9"},{"key":"25","unstructured":"25. Food and Drug Administration of The United States. Statistical Review and Evaluation, Clinical Studies (Glucovance).  2004. Available at https:\/\/www.fda.gov\/media\/91630\/download. Accessed October 1, 2021."},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Mitanchez-Mokhtari, D, Lahlou, N, Kieffer, F, Magny, JF, Roger, M, Voyer, M. Both relative insulin resistance and defective islet \u03b2-cell processing of proinsulin are responsible for transient hyperglycemia in extremely preterm infants. Pediatrics 2004;113: 537\u201341.","DOI":"10.1542\/peds.113.3.537"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Akhlaghi, F, Matson, KL, Mohammadpour, AH, Kelly, M, Karimani, A. Clinical pharmacokinetics and pharmacodynamics of antihyperglycemic medications in children and adolescents with type 2 diabetes mellitus. Clin Pharmacokinet 2017;56: 561\u201371.","DOI":"10.1007\/s40262-016-0472-6"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Treluyer, JM, Gueret, G, Cheron, G, Sonnier, M, Cresteil, T. Developmental expression of CYP2C and CYP2C-dependent activities in the human liver: in-vivo\/in-vitro correlation and inducibility. Pharmacogenetics 1997;7: 441\u201352.","DOI":"10.1097\/00008571-199712000-00002"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Rafiq, M, Flanagan, SE, Patch, AM, Shields, BM, Ellard, S, Hattersley, AT, Neonatal Diabetes International Collaborative Group. Effective treatment with oral sulfonylureas in patients with diabetes due to sulfonylurea receptor 1 (SUR1) mutations. Diabetes Care 2008;31: 204\u20139.","DOI":"10.2337\/dc07-1785"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Ng, SM, May, JE, Emmerson, AJ. Continuous insulin infusion in hyperglycaemic extremely-low- birth-weight neonates. Biol Neonate 2005;87: 269\u201372.","DOI":"10.1159\/000083863"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Verstappen, S, Mul, D. A \u2018picturesque\u2019 case of transition from subcutaneous to oral treatment in neonatal diabetes. BMJ Case Rep 2014;2014: 2013\u20135.","DOI":"10.1136\/bcr-2013-202912"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Oka, H, Suzuki, S, Furuya, A, Matsuo, K, Amamiya, S, Oshima, M, et al. Glycemic control and motor development in a patient with intermediate DEND. Pediatr Int 2014;56: 432\u20135.","DOI":"10.1111\/ped.12294"},{"key":"33","unstructured":"33. EUROPEAN MEDICINES AGENCY Amglidia. Available at https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/amglidia. Accessed October 6, 2021."}],"container-title":["Clinical Pediatric Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/cpe\/31\/4\/31_2022-0018\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T01:55:57Z","timestamp":1715219757000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/cpe\/31\/4\/31_2022-0018\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1297\/cpe.2022-0018","relation":{},"ISSN":["0918-5739","1347-7358"],"issn-type":[{"value":"0918-5739","type":"print"},{"value":"1347-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"article-number":"2022-0018"}}